Onxeo S.A.: Onxeo Appoints Julien Miara as New Interim CEO :

Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, First North Copenhagen: ONXEO), ("Onxeo" or "the Company"), a clinical-stage biotechnology company specializing in the development of innovative

Related Keywords

Paris , France General , France , Copenhagen , Køavn , Denmark , Nicolas Merigeau , Julien Miara , Emmanuel Huynh , Brian Ritchie , Shefali Agarwal , Onxeo Sa Euronext , Gustave Roussy , Institut Curie , Company Group , Nasdaq , Regulatory News , Euronext Growth Paris , First North Copenhagen , Chief Executive Officer , Invus Public Equities , Euronext Paris , Inhibitor Administered Intravenously , Relations Investisseurs , Investisseurs Communication , Sci Advisors , North Kapital Partner , Onxeo , Ppoints , Julien , Tiara , Interim ,